Urology
Volume 75, Issue 6 , Page 1282 , June 2010

Editorial Comment

References 

  1. Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—Part I: definition, detection, prevalence, and etiology. Urology. 2001;57:599–603
  2. Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001;57:604–610
  3. Nieder AM, Lotan Y, Nuss GR, et al. Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol, in press.
  4. Paez A, Coba JM, Murillo N, et al. Reliability of the routine cytological diagnosis in bladder cancer. Eur Urol. 1999;35:228–232
  5. Raitanen MP, Aine R, Rintala E, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer (An interobserver multicenter analysis). Eur Urol. 2002;41:284–289
  6. Nabi G, Greene DR, O'Donnell M. How important is urinary cytology in the diagnosis of urological malignancies?. Eur Urol. 2003;43:632–636
  7. Nabi G, Greene D, O'Donnell MO. Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?. J Clin Pathol. 2004;57:365–368
  8. Raitanen MP, Aine R, Kylmala T, et al. The dilemma of suspicious urine cytology in patients being followed for bladder cancer. Ann Chir Gynaecol. 2001;90:256–259

PII: S0090-4295(09)02946-X

doi: 10.1016/j.urology.2009.10.066

Urology
Volume 75, Issue 6 , Page 1282 , June 2010

Article Tools